Registered report: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology

eLife

Volumn 4, Issue September2015, 2015, Pages

  Cowley, Dale ^a   Pandya, Kumar ^a   Khan, Israr ^b   Kerwin, John ^c   Owen, Kate ^d   Griner, Erin ^d   Iorns, Elizabeth ^e   Gunn, William ^f   Tan, Fraser ^e   Lomax, Joelle ^e   Perfito, Nicole ^e   Errington, Timothy ^g  

^a TransViragen Inc   (United States)

^b Alamo Laboratories Inc   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e Science Exchange   (United States)

^f ELSEVIER MASSON   (France)

^g CENTER FOR OPEN SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 19B; MICRORNA 20A; UNCLASSIFIED DRUG; MESSENGER RNA;

ARTICLE; CELL GROWTH ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; FLUORESCENCE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; ONCOGENE; POLYMERASE CHAIN REACTION; PROSTATE CANCER CELL LINE; PSEUDOGENE; PTEN ONCOGENE; PTENP1 ONCOGENE; QUALITY CONTROL; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHORT TANDEM REPEAT; WESTERN BLOTTING; GENE; GENE EXPRESSION REGULATION; METABOLISM; REPRODUCIBILITY; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENES; HUMANS; PSEUDOGENES; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER;

EID: 85000365314     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.08245     Document Type: Article

References (41)

1. Bauer TM, Patel MR, Infante JR. 2014. Targeting PI3 kinase in cancer. Pharmacology & Therapeutics 146: 53-60. doi: 10. 1016/j. pharmthera. 2014. 09. 006.
2. Broderick JA, Zamore PD. 2014. Competitive endogenous RNAs cannot alter microRNA function in vivo. Molecular Cell 54: 711-713. doi: 10. 1016/j. molcel. 2014. 05. 023.
3. Carracedo A, Salmena L, Pandolfi PP. 2008. SnapShot: PTEN signaling pathways. Cell 133: 550. e1. doi: 10. 1016/j. cell. 2008. 04. 023.
4. Cesana M, Daley GQ. 2013. Deciphering the rules of ceRNA networks. Proceedings of the National Academy of Sciences of USA 110: 7112-7113. doi: 10. 1073/pnas. 1305322110.
5. Chan JA, Krichevsky AM, Kosik KS. 2005. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Research 65: 6029-6033. doi: 10. 1158/0008-5472. CAN-05-0137.
6. Chen CL, Tseng YW, Wu JC, Chen GY, Lin KC, Hwang SM, Hu YC. 2015. Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA PTENP1 and MicroRNA regulation. Biomaterials 44: 71-81. doi: 10. 1016/j. biomaterials. 2014. 12. 023.
7. Chen H, Mei L, Zhou L, Shen X, Guo C, Zheng Y, Zhu H, Zhu Y, Huang L. 2011. PTEN restoration and PIK3CB knockdown synergistically suppress glioblastoma growth in vitro and in xenografts. Journal of Neuro-Oncology 104: 155-167. doi: 10. 1007/s11060-010-0492-2.
8. Denzler R, Agarwal V, Stefano J, Bartel DP, Stoffel M. 2014. Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance. Molecular Cell 54: 766-776. doi: 10. 1016/j. molcel. 2014. 03. 045.
9. Errington TM, Iorns E, Gunn W, Tan FE, Lomax J, Nosek BA. 2014. An open investigation of the reproducibility of cancer biology research. eLife 3: e04333. doi: 10. 7554/eLife. 04333.
10. Faul F, Erdfelder E, Lang AG, Buchner A. 2007. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods 39: 175-191. doi: 10. 3758/BF03193146.
11. Franco-Zorrilla JM, Valli A, Todesco M, Mateos I, Puga MI, Rubio-Somoza I, Leyva A, Weigel D, Garcia JA, Paz-Ares J. 2007. Target mimicry provides a new mechanism for regulation of microRNA activity. Nature Genetics 39: 1033-1037. doi: 10. 1038/ng2079.
12. Fujii GH, Morimoto AM, Berson AE, Bolen JB. 1999. Transcriptional analysis of the PTEN/MMAC1 pseudogene, psiPTEN. Oncogene 18: 1765-1769. doi: 10. 1038/sj. onc. 1202492.
13. Fullwood MJ, Liu MH, Pan YF, Liu J, Xu H, Mohamed YB, Orlov YL, Velkov S, Ho A, Mei PH, Chew EG, Huang PY, Welboren WJ, Han Y, Ooi HS, Ariyaratne PN, Vega VB, Luo Y, Tan PY, Choy PY, Wansa KD, Zhao B, Lim KS, Leow SC, Yow JS, Joseph R, Li H, Desai KV, Thomsen JS, Lee YK, Karuturi RK, Herve T, Bourque G, Stunnenberg HG, Ruan X, Cacheux-Rataboul V, Sung WK, Liu ET, Wei CL, Cheung E, Ruan Y. 2009. An oestrogen-receptor-alphabound human chromatin interactome. Nature 462: 58-64. doi: 10. 1038/nature08497.
14. Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P, Varela I, Phillimore B, Begum S, McDonald NQ, Butler A, Jones D, Raine K, Latimer C, Santos CR, Nohadani M, Eklund AC, Spencer-Dene B, Clark G, Pickering L, Stamp G, Gore M, Szallasi Z, Downward J, Futreal PA, Swanton C. 2012. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. The New England Journal of Medicine 366: 883-892. doi: 10. 1056/NEJMoa1113205.
15. Guo X, Deng L, Deng K, Wang H, Shan T, Zhou H, Liang Z, Xia J, Li C. 2015. Pseudogene PTENP1 suppresses gastric cancer progression by modulating PTEN. Anti-Cancer Agents in Medicinal Chemistry.
16. Hopkins BD, Parsons RE. 2014. Molecular pathways: intercellular PTEN and the potential of PTEN restoration therapy. Clinical Cancer Research 20: 5379-5383. doi: 10. 1158/1078-0432. CCR-13-2661.
17. Jackson BL, Grabowska A, Ratan HL. 2014. MicroRNA in prostate cancer: functional importance and potential as circulating biomarkers. BMC Cancer 14: 930. doi: 10. 1186/1471-2407-14-930.
18. Karreth FA, Tay Y, Perna D, Ala U, Tan SM, Rust AG, DeNicola G, Webster KA, Weiss D, Perez-Mancera PA, Krauthammer M, Halaban R, Provero P, Adams DJ, Tuveson DA, Pandolfi PP. 2011. In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell 147: 382-395. doi: 10. 1016/j. cell. 2011. 09. 032.
19. Lee DY, Jeyapalan Z, Fang L, Yang J, Zhang Y, Yee AY, Li M, Du WW, Shatseva T, Yang BB. 2010. Expression of versican 3'-untranslated region modulates endogenous microRNA functions. PLOS ONE 5: e13599. doi: 10. 1371/journal. pone. 0013599.
20. Li J, Simpson L, Takahashi M, Miliaresis C, Myers MP, Tonks N, Parsons R. 1998. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene. Cancer Research 58: 5667-5672.
21. Lu Y, Lin YZ, LaPushin R, Cuevas B, Fang X, Yu SX, Davies MA, Khan H, Furui T, Mao M, Zinner R, Hung MC, Steck P, Siminovitch K, Mills GB. 1999. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Oncogene 18: 7034-7045. doi: 10. 1038/sj. onc. 1203183.
22. Luo X, Dong Z, Chen Y, Yang L, Lai D. 2013. Enrichment of ovarian cancer stem-like cells is associated with epithelial to mesenchymal transition through an miRNA-activated AKT pathway. Cell Proliferation 46: 436-446. doi: 10. 1111/cpr. 12038.
23. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, Jiang J, Schmittgen TD, Patel T. 2006. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130: 2113-2129. doi: 10. 1053/j. gastro. 2006. 02. 057.
24. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. 2007. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658. doi: 10. 1053/j. gastro. 2007. 05. 022.
25. Phin S, Moore MW, Cotter PD. 2013. Genomic rearrangements of PTEN in prostate Cancer. Frontiers in Oncology 3: 240. doi: 10. 3389/fonc. 2013. 00240.
26. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP. 2010. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465: 1033-1038. doi: 10. 1038/nature09144.
27. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. 2011. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146: 353-358. doi: 10. 1016/j. cell. 2011. 07. 014.
28. Sen R, Ghosal S, Das S, Balti S, Chakrabarti J. 2014. Competing endogenous RNA: the key to posttranscriptional regulation. Thescientificworldjournal 2014: 896206. doi: 10. 1155/2014/896206.
29. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY. 2007. miR-21-mediated tumor growth. Oncogene 26: 2799-2803. doi: 10. 1038/sj. onc. 1210083.
30. Song MS, Salmena L, Pandolfi PP. 2012. The functions and regulation of the PTEN tumour suppressor. Nature Reviews. Molecular Cell Biology 13: 283-296. doi: 10. 1038/nrm3330.
31. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW. 1998. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95: 29-39. doi: 10. 1016/S0092-8674(00)81780-8.
32. Sumazin P, Yang X, Chiu HS, Chung WJ, Iyer A, Llobet-Navas D, Rajbhandari P, Bansal M, Guarnieri P, Silva J, Califano A. 2011. An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma. Cell 147: 370-381. doi: 10. 1016/j. cell. 2011. 09. 041.
33. Tay Y, Kats L, Salmena L, Weiss D, Tan SM, Ala U, Karreth F, Poliseno L, Provero P, Di Cunto F, Lieberman J, Rigoutsos I, Pandolfi PP. 2011. Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 147: 344-357. doi: 10. 1016/j. cell. 2011. 09. 029.
34. R Development Core Team. 2014. R: A language and environment for statistical computing. R Foundation for Statistical Computing. http://www. R-project. org/.
35. Tian L, Fang YX, Xue JL, Chen JZ. 2013. Four microRNAs promote prostate cell proliferation with regulation of PTEN and its downstream signals in vitro. PLOS ONE 8: e75885. doi: 10. 1371/journal. pone. 0075885.
36. Tian XX, Pang JC, To SS, Ng HK. 1999. Restoration of wild-type PTEN expression leads to apoptosis, induces differentiation, and reduces telomerase activity in human glioma cells. Journal of Neuropathology and Experimental Neurology 58: 472-479. doi: 10. 1097/00005072-199905000-00006.
37. Trotman LC, Niki M, Dotan ZA, Koutcher JA, Di Cristofano A, Xiao A, Khoo AS, Roy-Burman P, Greenberg NM, Van Dyke T, Cordon-Cardo C, Pandolfi PP. 2003. Pten dose dictates cancer progression in the prostate. PLOS Biology 1: E59. doi: 10. 1371/journal. pbio. 0000059.
38. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proceedings of the National Academy of Sciences of USA 103: 2257-2261. doi: 10. 1073/pnas. 0510565103.
39. Wang J, Du Y, Liu X, Cho WC, Yang Y. 2015. MicroRNAs as regulator of signaling networks in metastatic colon cancer. Biomed Research International 2015: 823620. doi: 10. 1155/2015/823620.
40. Wu TY, Zhang TH, Qu LM, Feng JP, Tian LL, Zhang BH, Li DD, Sun YN, Liu M. 2014. MiR-19a is correlated with prognosis and apoptosis of laryngeal squamous cell carcinoma by regulating TIMP-2 expression. International Journal of Clinical and Experimental Pathology 7: 56-63.
41. Yu G, Yao W, Gumireddy K, Li A, Wang J, Xiao W, Chen K, Xiao H, Li H, Tang K, Ye Z, Huang Q, Xu H. 2014. Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression. Molecular Cancer Therapeutics 13: 3086-3097. doi: 10. 1158/1535-7163. MCT-14-0245.